Breaking News Instant updates and real-time market news.

INSM

Insmed

$31.58

1.04 (3.41%)

09:31
04/24/19
04/24
09:31
04/24/19
09:31

Insmed management to meet with SVB Leerink

Meeting to be held in San Francisco on April 24 hosted by SVB Leerink.

  • 24

    Apr

  • 16

    May

  • 23

    Jun

INSM Insmed
$31.58

1.04 (3.41%)

02/15/19
JMPS
02/15/19
UPGRADE
Target $40
JMPS
Outperform
Insmed upgraded to Outperform following Arikayce survey at JMP Securities
As previously reported, JMP Securities analyst Liisa Bayko upgraded Insmed to Outperform from Market Perform, stating that her survey of "early adopters" of Arikayce shows a high rate of utilization with a favorable early experience that is encouraging more usage. This suggests Arikayce will beat 2019 consensus, contends Bayko, who raised her 2019 Arikayce revenue estimates. She set a $40 price target on Insmed shares.
03/08/19
ADAM
03/08/19
NO CHANGE
Target $44
ADAM
Buy
Insmed price target raised to $44 from $32 at Canaccord
Canaccord analyst Dewey Steadman raised his price target on Insmed to $44 from $32 following Q4 results. The analyst was impressed with the Arikayce uptake to-date and he thinks its initial guidance leaves room for a beat once Medicare dynamics are fully understood. He also sees continued growth in the Arikayce franchise and its pulmonary pipeline provides additional upside optionality. Steadman reiterated his Buy rating on Insmed shares.
03/26/19
STFL
03/26/19
NO CHANGE
Target $43
STFL
Buy
Pulmonologist call reinforces Stifel view of upside for Insmed
After hosting a conference call with two key opinion leader pulmonologists to discuss the rollout of Arikayce, Stifel analyst Adam Walsh said their feedback suggested the strong start for the drug was not the result of a "bolus" of patients awaiting approval and noted that both doctors said their new-patient starts remain steady. While it "remains early days in the launch," the call with the doctors reinforced his belief that Insmed's Arikayce guidance is likely conservative, Walsh tells investors. He keeps a Buy rating and $43 price target on Insmed shares.
04/09/19
HCWC
04/09/19
NO CHANGE
Target $52
HCWC
Buy
Insmed price target raised to $52 from $43 at H.C. Wainwright
H.C. Wainwright analyst Andrew Fein raised his price target for Insmed to $52 from $43 saying the company yesterday announced a positive update on the U.S. launch of Arikayce. The broadening of the prescriber base "is not short lived and can continue, as well as possibly be supplemented by label expansion into first line patients," Fein tells investors in a research note. He keeps a Buy rating on the shares.

TODAY'S FREE FLY STORIES

JMIA

Jumia Technologies

$25.42

-0.26 (-1.01%)

12:20
06/24/19
06/24
12:20
06/24/19
12:20
Periodicals
Jumia Food eyes Africa's middle class to boost growth, Reuters says »

Jumia Food, Jumia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETFC

E-Trade

$44.83

-1.4 (-3.03%)

12:20
06/24/19
06/24
12:20
06/24/19
12:20
Options
E Trade put seller opens August 40 strike position »

E Trade put seller opens…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

T

AT&T

$32.59

0.13 (0.40%)

12:18
06/24/19
06/24
12:18
06/24/19
12:18
Hot Stocks
AT&T's WarnerMedia appoints Ann Sarnoff CEO of Warner Bros. »

WarnerMedia CEO John…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

FTD

FTD Companies

$0.00

(0.00%)

12:17
06/24/19
06/24
12:17
06/24/19
12:17
Hot Stocks
FTD Companies enters into asset purchase agreement for Personal Creations »

FTD Companies provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
06/24/19
06/24
12:17
06/24/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
06/24/19
06/24
12:16
06/24/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$45.94

-3.42 (-6.93%)

, CELG

Celgene

$93.98

-4.94 (-4.99%)

12:15
06/24/19
06/24
12:15
06/24/19
12:15
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks are mildly higher…

BMY

Bristol-Myers

$45.94

-3.42 (-6.93%)

CELG

Celgene

$93.98

-4.94 (-4.99%)

ERI

Eldorado Resorts

$45.74

-5.48 (-10.70%)

CZR

Caesars

$11.52

1.53 (15.32%)

PCMI

PCM, Inc.

$34.71

10.36 (42.55%)

NSIT

Insight Enterprises

$57.56

1.37 (2.44%)

KRYS

Krystal Biotech

$37.20

7.92 (27.05%)

SBH

Sally Beauty

$12.94

-1.85 (-12.51%)

AMZN

Amazon.com

$1,909.00

-1.42 (-0.07%)

WAB

Wabtec

$68.53

-4.22 (-5.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 24

    Jun

  • 24

    Jun

  • 24

    Jun

  • 25

    Jun

  • 25

    Jun

  • 27

    Jun

  • 02

    Jul

  • 10

    Jul

  • 25

    Jul

  • 03

    Sep

  • 16

    Sep

  • 13

    Nov

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

SRPT

Sarepta

$128.78

-1.13 (-0.87%)

12:15
06/24/19
06/24
12:15
06/24/19
12:15
Options
Sarepta put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

ENS

EnerSys

$66.07

0.2997 (0.46%)

12:07
06/24/19
06/24
12:07
06/24/19
12:07
Conference/Events
EnerSys management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

  • 26

    Jun

  • 27

    Jun

GBT

Global Blood Therapeutics

$64.21

1.2 (1.90%)

12:05
06/24/19
06/24
12:05
06/24/19
12:05
Options
Global Blood Therapeutics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRYS

Krystal Biotech

$37.20

7.92 (27.05%)

12:03
06/24/19
06/24
12:03
06/24/19
12:03
Recommendations
Krystal Biotech analyst commentary  »

Krystal Biotech price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

CNC

Centene

$55.52

-0.86 (-1.53%)

, WCG

WellCare

$296.08

-3.1 (-1.04%)

12:01
06/24/19
06/24
12:01
06/24/19
12:01
Hot Stocks
Centene, WellCare stockholders approve proposals regarding WellCare acquisition »

Centene Corporation (CNC)…

CNC

Centene

$55.52

-0.86 (-1.53%)

WCG

WellCare

$296.08

-3.1 (-1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 24

    Jun

  • 23

    Jul

QUAD

Quad/Graphics

$8.16

-0.94 (-10.33%)

12:00
06/24/19
06/24
12:00
06/24/19
12:00
Hot Stocks
Quad/Graphics falls -10.5% »

Quad/Graphics is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBH

Sally Beauty

$13.02

-1.77 (-11.97%)

12:00
06/24/19
06/24
12:00
06/24/19
12:00
Hot Stocks
Sally Beauty falls -11.9% »

Sally Beauty is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$171.00

-25.38 (-12.92%)

12:00
06/24/19
06/24
12:00
06/24/19
12:00
Hot Stocks
VelocityShares 3x Inv Natural Gas ETN falls -13.0% »

VelocityShares 3x Inv…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTEC

Rudolph Technologies

$27.82

2.81 (11.24%)

12:00
06/24/19
06/24
12:00
06/24/19
12:00
Hot Stocks
Rudolph Technologies rises 11.0% »

Rudolph Technologies is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 10

    Jul

TLRD

Tailored Brands

$6.16

0.62 (11.19%)

12:00
06/24/19
06/24
12:00
06/24/19
12:00
Hot Stocks
Tailored Brands rises 11.0% »

Tailored Brands is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UGAZ

VelocityShares 3x Long Natural Gas ETN

$15.45

1.71 (12.45%)

12:00
06/24/19
06/24
12:00
06/24/19
12:00
Hot Stocks
VelocityShares 3x Long Natural Gas ETN rises 12.6% »

VelocityShares 3x Long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:55
06/24/19
06/24
11:55
06/24/19
11:55
General news
Treasury's $72 B 3- and 6-month bill auctions were ok but sloppy »

Treasury's $72 B 3-…

INGN

Inogen

$72.22

0.93 (1.30%)

11:55
06/24/19
06/24
11:55
06/24/19
11:55
Conference/Events
William Blair medical tech analyst to hold a luncheon »

Medical Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 26

    Aug

GTLS

Chart Industries

$70.49

0.33 (0.47%)

11:54
06/24/19
06/24
11:54
06/24/19
11:54
Conference/Events
Chart Industries management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 11

    Jul

SPY

SPDR S&P 500 ETF Trust

$294.30

0.31 (0.11%)

, SPX

S&P 500

$0.00

(0.00%)

11:50
06/24/19
06/24
11:50
06/24/19
11:50
General news
Trump signing executive order for 'strong sanctions' on Iran, Bloomberg reports »

Bloomberg quotes…

SPY

SPDR S&P 500 ETF Trust

$294.30

0.31 (0.11%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAL

Halliburton

$22.55

-0.28 (-1.23%)

11:50
06/24/19
06/24
11:50
06/24/19
11:50
Options
Halliburton trader exits late-may risk-reversal for a loss »

Halliburton trader exits…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 27

    Aug

  • 13

    Nov

KRYS

Krystal Biotech

$37.20

7.92 (27.05%)

11:46
06/24/19
06/24
11:46
06/24/19
11:46
Recommendations
Krystal Biotech analyst commentary  »

Krystal Biotech price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

TLRD

Tailored Brands

$6.11

0.565 (10.20%)

11:45
06/24/19
06/24
11:45
06/24/19
11:45
Options
Tailored Brands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.